Amaroq Ltd. logo

Amaroq Ltd. (AMRQ)

Market Closed
10 Aug, 15:30
LSE LSE
106. 00
GBX
0
0%
GBX
- Market Cap
- P/E Ratio
- Div Yield
274,027 Volume
- Eps
106 GBX
Previous Close
Add Transaction
Day Range
105 107
Year Range
60 155
Want to track AMRQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

AMRQ closed today higher at 106 GBX, an increase of 0% from yesterday's close, completing a monthly increase of 28.4848% or 23.5 GBX. Over the past 12 months, AMRQ stock lost -0.9346%.
AMRQ is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on LSE (GBX).

AMRQ Chart

Amaroq Ltd. (AMRQ) FAQ

What is the stock price today?

The current price is 106.00 GBX.

On which exchange is it traded?

Amaroq Ltd. is listed on LSE.

What is its stock symbol?

The ticker symbol is AMRQ.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Amaroq Ltd. ever had a stock split?

No, there has never been a stock split.

Amaroq Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
LSE Exchange
- ISIN
Germany Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Viromed Medical AG, formerly known as Fonterelli SPAC2 AG, is a pioneering company based in Pinneberg, Germany. Since its incorporation in 2021, the company has focused on the development and distribution of innovative products across diagnostics, therapeutics, and cold plasma technology. With a mission to revolutionize medical solutions and healthcare, Viromed Medical AG is positioned at the cutting edge of medical technology, committed to improving patient outcomes through its advanced product offerings and research initiatives.

Products and Services

  • Diagnostics

    Viromed Medical AG offers a range of diagnostic tools and kits designed for the detection and monitoring of various diseases. These products leverage the latest advancements in biotechnology to provide accurate, timely, and cost-effective diagnostic solutions for healthcare providers and patients alike.

  • Therapeutics

    The company develops and distributes a variety of therapeutic products aimed at treating and managing a wide spectrum of conditions. By focusing on innovation and efficacy, Viromed Medical AG delivers novel therapeutic options that contribute to better health outcomes and improve the quality of life for patients undergoing treatment.

  • Cold Plasma Technology

    One of Viromed Medical AG's most groundbreaking service areas is the application of cold plasma technology in medicine. This cutting-edge technology offers a non-invasive, highly effective approach to sterilization, wound healing, and possibly even cancer treatment. Cold plasma technology represents a significant step forward in medical science, showcasing Viromed Medical AG's commitment to leading the way in healthcare innovation.

Contact Information

Address: Flensburger Straße 18
Phone: 49 4101 809960